Dietary vitamin B6 intake and the risk of colorectal cancer

Evropi Theodoratou, Susan M. Farrington, Albert Tenesa, Geraldine McNeill, Roseanne Cetnarskyj, Rebecca A. Barnetson, Mary E. Porteous, Malcolm G. Dunlop, Harry Campbelll

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Vitamin B6, a coenzyme in the folate metabolism pathway, may have anticarcinogenic effects. Laboratory and epidemiologic studies support the hypothesis of its protective effect against colorectal cancer (CRC). The aim of this large Scottish case-control study, including 2,028 hospital-based cases and 2,722 population-based controls, was to investigate the associations between dietary and supplementary intake of vitamin B6 and CRC. Three logistic regression models adjusted for several confounding factors, including energy, folate, and fiber intake, were applied in the whole sample and after age, sex, cancer site, folate, MTHFR C677T (rs1801133), MTHFR A1298C (rs1801131), MTR A2756G (rs1805087), and MTRR A66G (rs1801394) stratification (analysis on genotypes on 1,001 cases and 1,010 controls :! 55 years old). Moderately strong inverse and dose-dependent associations in the whole sample were found between CRC risk and the intake of dietary and total vitamin B6 in all three models [model III: odds ratio (OR), 0.77, 95% confidence interval (95% CI), 0.61-0.98; P for trend = 0.03; OR, 0.86; 95% CI, 0.69-1.07; P for trend = 0.121. In addition, meta-analyses of published studies showed inverse associations between vitamin B6 and CRC (combined relative risk, 0.81; 95% CI, 0.68-0.96; test for overall effect P = 0.01; combined odds ratio, 0.67; 95% CI, 0.60-0.75; test for overall effect P < 0.00001). Analysis within the stratified subgroups showed similar associations apart from a stronger effect among :<= 55-year-old individuals. Evidence from larger cohort and experimental studies is now required to confirm and define the anticarcinogenic actions of vitamin B6 and to explore the mechanisms by which this effect is mediated.

Original languageEnglish
Pages (from-to)171-182
Number of pages12
JournalCancer Epidemiology, Biomarkers and Prevention
Volume17
DOIs
Publication statusPublished - Jan 2008

Keywords

  • folate metabolism
  • co9lon-cancer
  • DNA methylation
  • MTHFR C677T
  • polymorphisms
  • women
  • carcinogenesis
  • micronutrients
  • metaanalysis
  • methionine
  • colorectal neoplasms
  • case-control studies
  • diet
  • logistic models
  • vitamin B6

Cite this

Theodoratou, E., Farrington, S. M., Tenesa, A., McNeill, G., Cetnarskyj, R., Barnetson, R. A., ... Campbelll, H. (2008). Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiology, Biomarkers and Prevention, 17, 171-182. https://doi.org/10.1158/1055-9965.EPI-07-0621

Dietary vitamin B6 intake and the risk of colorectal cancer. / Theodoratou, Evropi; Farrington, Susan M.; Tenesa, Albert; McNeill, Geraldine; Cetnarskyj, Roseanne; Barnetson, Rebecca A.; Porteous, Mary E.; Dunlop, Malcolm G.; Campbelll, Harry.

In: Cancer Epidemiology, Biomarkers and Prevention, Vol. 17, 01.2008, p. 171-182.

Research output: Contribution to journalArticle

Theodoratou, E, Farrington, SM, Tenesa, A, McNeill, G, Cetnarskyj, R, Barnetson, RA, Porteous, ME, Dunlop, MG & Campbelll, H 2008, 'Dietary vitamin B6 intake and the risk of colorectal cancer', Cancer Epidemiology, Biomarkers and Prevention, vol. 17, pp. 171-182. https://doi.org/10.1158/1055-9965.EPI-07-0621
Theodoratou, Evropi ; Farrington, Susan M. ; Tenesa, Albert ; McNeill, Geraldine ; Cetnarskyj, Roseanne ; Barnetson, Rebecca A. ; Porteous, Mary E. ; Dunlop, Malcolm G. ; Campbelll, Harry. / Dietary vitamin B6 intake and the risk of colorectal cancer. In: Cancer Epidemiology, Biomarkers and Prevention. 2008 ; Vol. 17. pp. 171-182.
@article{4c0918d5964547b987e9e54d5a052e48,
title = "Dietary vitamin B6 intake and the risk of colorectal cancer",
abstract = "Vitamin B6, a coenzyme in the folate metabolism pathway, may have anticarcinogenic effects. Laboratory and epidemiologic studies support the hypothesis of its protective effect against colorectal cancer (CRC). The aim of this large Scottish case-control study, including 2,028 hospital-based cases and 2,722 population-based controls, was to investigate the associations between dietary and supplementary intake of vitamin B6 and CRC. Three logistic regression models adjusted for several confounding factors, including energy, folate, and fiber intake, were applied in the whole sample and after age, sex, cancer site, folate, MTHFR C677T (rs1801133), MTHFR A1298C (rs1801131), MTR A2756G (rs1805087), and MTRR A66G (rs1801394) stratification (analysis on genotypes on 1,001 cases and 1,010 controls :! 55 years old). Moderately strong inverse and dose-dependent associations in the whole sample were found between CRC risk and the intake of dietary and total vitamin B6 in all three models [model III: odds ratio (OR), 0.77, 95{\%} confidence interval (95{\%} CI), 0.61-0.98; P for trend = 0.03; OR, 0.86; 95{\%} CI, 0.69-1.07; P for trend = 0.121. In addition, meta-analyses of published studies showed inverse associations between vitamin B6 and CRC (combined relative risk, 0.81; 95{\%} CI, 0.68-0.96; test for overall effect P = 0.01; combined odds ratio, 0.67; 95{\%} CI, 0.60-0.75; test for overall effect P < 0.00001). Analysis within the stratified subgroups showed similar associations apart from a stronger effect among :<= 55-year-old individuals. Evidence from larger cohort and experimental studies is now required to confirm and define the anticarcinogenic actions of vitamin B6 and to explore the mechanisms by which this effect is mediated.",
keywords = "folate metabolism, co9lon-cancer, DNA methylation, MTHFR C677T, polymorphisms, women, carcinogenesis, micronutrients, metaanalysis, methionine, colorectal neoplasms, case-control studies, diet, logistic models, vitamin B6",
author = "Evropi Theodoratou and Farrington, {Susan M.} and Albert Tenesa and Geraldine McNeill and Roseanne Cetnarskyj and Barnetson, {Rebecca A.} and Porteous, {Mary E.} and Dunlop, {Malcolm G.} and Harry Campbelll",
year = "2008",
month = "1",
doi = "10.1158/1055-9965.EPI-07-0621",
language = "English",
volume = "17",
pages = "171--182",
journal = "Cancer Epidemiology, Biomarkers and Prevention",
issn = "1055-9965",
publisher = "AMER ASSOC CANCER RESEARCH",

}

TY - JOUR

T1 - Dietary vitamin B6 intake and the risk of colorectal cancer

AU - Theodoratou, Evropi

AU - Farrington, Susan M.

AU - Tenesa, Albert

AU - McNeill, Geraldine

AU - Cetnarskyj, Roseanne

AU - Barnetson, Rebecca A.

AU - Porteous, Mary E.

AU - Dunlop, Malcolm G.

AU - Campbelll, Harry

PY - 2008/1

Y1 - 2008/1

N2 - Vitamin B6, a coenzyme in the folate metabolism pathway, may have anticarcinogenic effects. Laboratory and epidemiologic studies support the hypothesis of its protective effect against colorectal cancer (CRC). The aim of this large Scottish case-control study, including 2,028 hospital-based cases and 2,722 population-based controls, was to investigate the associations between dietary and supplementary intake of vitamin B6 and CRC. Three logistic regression models adjusted for several confounding factors, including energy, folate, and fiber intake, were applied in the whole sample and after age, sex, cancer site, folate, MTHFR C677T (rs1801133), MTHFR A1298C (rs1801131), MTR A2756G (rs1805087), and MTRR A66G (rs1801394) stratification (analysis on genotypes on 1,001 cases and 1,010 controls :! 55 years old). Moderately strong inverse and dose-dependent associations in the whole sample were found between CRC risk and the intake of dietary and total vitamin B6 in all three models [model III: odds ratio (OR), 0.77, 95% confidence interval (95% CI), 0.61-0.98; P for trend = 0.03; OR, 0.86; 95% CI, 0.69-1.07; P for trend = 0.121. In addition, meta-analyses of published studies showed inverse associations between vitamin B6 and CRC (combined relative risk, 0.81; 95% CI, 0.68-0.96; test for overall effect P = 0.01; combined odds ratio, 0.67; 95% CI, 0.60-0.75; test for overall effect P < 0.00001). Analysis within the stratified subgroups showed similar associations apart from a stronger effect among :<= 55-year-old individuals. Evidence from larger cohort and experimental studies is now required to confirm and define the anticarcinogenic actions of vitamin B6 and to explore the mechanisms by which this effect is mediated.

AB - Vitamin B6, a coenzyme in the folate metabolism pathway, may have anticarcinogenic effects. Laboratory and epidemiologic studies support the hypothesis of its protective effect against colorectal cancer (CRC). The aim of this large Scottish case-control study, including 2,028 hospital-based cases and 2,722 population-based controls, was to investigate the associations between dietary and supplementary intake of vitamin B6 and CRC. Three logistic regression models adjusted for several confounding factors, including energy, folate, and fiber intake, were applied in the whole sample and after age, sex, cancer site, folate, MTHFR C677T (rs1801133), MTHFR A1298C (rs1801131), MTR A2756G (rs1805087), and MTRR A66G (rs1801394) stratification (analysis on genotypes on 1,001 cases and 1,010 controls :! 55 years old). Moderately strong inverse and dose-dependent associations in the whole sample were found between CRC risk and the intake of dietary and total vitamin B6 in all three models [model III: odds ratio (OR), 0.77, 95% confidence interval (95% CI), 0.61-0.98; P for trend = 0.03; OR, 0.86; 95% CI, 0.69-1.07; P for trend = 0.121. In addition, meta-analyses of published studies showed inverse associations between vitamin B6 and CRC (combined relative risk, 0.81; 95% CI, 0.68-0.96; test for overall effect P = 0.01; combined odds ratio, 0.67; 95% CI, 0.60-0.75; test for overall effect P < 0.00001). Analysis within the stratified subgroups showed similar associations apart from a stronger effect among :<= 55-year-old individuals. Evidence from larger cohort and experimental studies is now required to confirm and define the anticarcinogenic actions of vitamin B6 and to explore the mechanisms by which this effect is mediated.

KW - folate metabolism

KW - co9lon-cancer

KW - DNA methylation

KW - MTHFR C677T

KW - polymorphisms

KW - women

KW - carcinogenesis

KW - micronutrients

KW - metaanalysis

KW - methionine

KW - colorectal neoplasms

KW - case-control studies

KW - diet

KW - logistic models

KW - vitamin B6

U2 - 10.1158/1055-9965.EPI-07-0621

DO - 10.1158/1055-9965.EPI-07-0621

M3 - Article

VL - 17

SP - 171

EP - 182

JO - Cancer Epidemiology, Biomarkers and Prevention

JF - Cancer Epidemiology, Biomarkers and Prevention

SN - 1055-9965

ER -